Genetic Technologies Limited
GNTLF
Other OTC1.00
USD
- -
- -
Total Valuation
Genetic Technologies Limited carries a market capitalization of 1.34B, placing it among publicly traded companies globally.
| Market Cap | 1.34B |
| Enterprise Value | N/A |
Financial Position
Genetic Technologies Limited maintains a current ratio of 2.55, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.55 |
| Quick Ratio | 2.17 |
| Debt / Equity | 55.76 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Stock Price Statistics
Genetic Technologies Limited's stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 1.00, while the 200-day moving average is 1.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 1.00 |
| Average Volume (20 Days) | N/A |
Cash Flow
| Operating Cash Flow | N/A |
| Capital Expenditures | -18,967.00 |
| Free Cash Flow | -18,967.00 |
| FCF Per Share | N/A |
Stock Splits
Genetic Technologies Limited's most recent stock split took place on December 14, 2023 with a 100:1 split ratio.
| Last Split Date | 12/14/2023 |
| Split Ratio | 100:1 |
Scores
Genetic Technologies Limited posts an Altman Z-Score of -93.38, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -93.38 |